These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15497758)

  • 1. Comparison of biodegradable nanoparticles and multiple emulsions (water-in-oil-in-water) containing influenza virus antigen on the in vivo immune response in rats.
    Bozkir A; Hayta G; Saka OM
    Pharmazie; 2004 Sep; 59(9):723-5. PubMed ID: 15497758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of multiple emulsions water-in-oil-in-water (w/o/w) as delivery system for influenza virus antigens.
    Bozkir A; Hayta G
    J Drug Target; 2004 Apr; 12(3):157-64. PubMed ID: 15203895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of water-in-oil-in-water multiple emulsion and microemulsion as potential adjuvants for immunization with rabies antigen.
    Leclercq SY; dos Santos RM; Macedo LB; Campos PC; Ferreira TC; de Almeida JG; Seniuk JG; Serakides R; Silva-Cunha A; Fialho SL
    Eur J Pharm Sci; 2011 Aug; 43(5):378-85. PubMed ID: 21627989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses.
    Jansen T; Hofmans MP; Theelen MJ; Schijns VE
    Vaccine; 2005 Jan; 23(8):1053-60. PubMed ID: 15620479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure- and oil type-based efficacy of emulsion adjuvants.
    Jansen T; Hofmans MP; Theelen MJ; Manders F; Schijns VE
    Vaccine; 2006 Jun; 24(26):5400-5. PubMed ID: 16675072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
    Han Y; Tian H; He P; Chen X; Jing X
    Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus.
    Sasaki T; Isoda N; Soda K; Sakamoto R; Saijo K; Hagiwara J; Kokumai N; Ohgitani T; Imamura T; Sawata A; Lin Z; Sakoda Y; Kida H
    Jpn J Vet Res; 2009 Feb; 56(4):189-98. PubMed ID: 19358446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of biodegradable polymeric hollow microspheres using O/O/W emulsion stabilized by Labrafil.
    Yoo HS
    Colloids Surf B Biointerfaces; 2006 Sep; 52(1):47-51. PubMed ID: 16930956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of phase inversion on the formation and stability of one-step multiple emulsions.
    Morais JM; Rocha-Filho PA; Burgess DJ
    Langmuir; 2009 Jul; 25(14):7954-61. PubMed ID: 19441778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hydrophilic surfactants on the properties of multiple W/O/W emulsions.
    Schmidts T; Dobler D; Nissing C; Runkel F
    J Colloid Interface Sci; 2009 Oct; 338(1):184-92. PubMed ID: 19595359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of emulsion stabilization with special reference to polymeric surfactants.
    Tadros T
    J Cosmet Sci; 2006; 57(2):153-69. PubMed ID: 16688378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C; Gupta V; Ahsan F
    Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.